Publication | Closed Access

RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines

InflammationRheumatologyInflammatory CytokinesAnti-inflammatoryAutoimmune DiseaseImmunologyOsteoarthritisInflammatory Rheumatic DiseaseNf-κb ActivationMedicineCell BiologyOrthopaedic SurgeryInflammatory ArthritisAttenuate Adjuvant